The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
adults with primary open-angle or pigment-dispersion glaucoma, or ocular hypertension
at baseline the intraocular pressure should be 20 to 32 mm Hg inclusive at 08:00 measurement (Visit 2) after dosing with timolol the evening before
the intraocular pressure should be 32 mm Hg or less at all the time points in both eyes at Visit 2
visual acuity should be 6/60 or better in the study eye(s)
any anticipated change in systemic hypotensive therapy during the trial
use of any corticosteroids by any route for more than two weeks during the study